11 postdoctoral-tissue-engineering positions at Radboud University Medical Center (Radboudumc)
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
stem cell-derived retinal in vitro models, complement assays, and antisense oligonucleotide and CRISPR-cas9 technology. Taks and responsibilities Design and lead experiments to record
-
an EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description We are looking for an ambitious postdoctoral researcher to investigate key regulators of CD20
-
programme Is the Job related to staff position within a Research Infrastructure? No Offer Description We are looking for an enthusiastic research technician with talent for tissue engineering and biochemistry
-
irradiate tumor lesions from inside the body. This approach allows for the delivery of a high radiation absorbed dose to (metastasized) tumor lesions, while sparing healthy tissues. Despite the high potential
-
tumor lesions from inside the body. This approach allows for the delivery of a high radiation absorbed dose to (metastasized) tumor lesions, while sparing healthy tissues. Despite the high potential
-
an EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description We are looking for an ambitious postdoctoral researcher to investigate key regulators of CD20
-
individual to join our team as a postdoctoral researcher in early Health Technology Assessment (HTA). This position offers an exciting opportunity to collaborate closely with innovators and clinicians, and to
-
points to overcome metastatic ability. The consortium forms a unique and highly interdisciplinary team that combines intravital microscopy with organ on a chip technology, in vivo cell biology
-
for a motivated Senior Research Assistant with expertise and knowledge in cancer immunotherapy and genetic engineering of (immune) cells. Join our exciting CAR-NK therapy program and translational
-
modifications and gene expression programs. In addition, a drug repurposing screen will be executed to determine whether known drugs exist that inhibit HMX3. State-of-the-art models (genetically engineered blood